We experience these industries. For example, we act in refinance arrangements and we assist banks and debtors in receivership and liquidation matters. We counsel in secured transactions, provision of credit facilities, loan participations, leveraged buy-outs, work-outs and the like. More technically, we advise on various license and permit requirements imposed by the Israeli financial system, on governmental, including Bank of Israel, regulations and various regulatory capital issues andon good banking practice.

The firm’s knowledge and experience support start-up and maturing biotech firms in their various rounds of financings, as well as pharmaceutical houses in their distribution arrangements and regulatory compliance needs. Firm lawyers are well-versed in licensing issues and have frequently counseled on disputes of intellectual property. The firm has advised a number of bio-tech and medical products clients on capital-raising issues.

The firm’s deep experience in banking and finance, corporate transactions, competition, mergers, acquisitions and joint ventures and litigation all contribute to a well-rounded ability to assist life science and pharma sector clients meet their needs and goals.